In summary, while PD-1 blockade in AD amplifies monocyte influx into the brain, MDP-activated NOD2 appears to shift the balance from classical to non-classical monocytes, concurrently enhancing monocyte recruitment. Here, NOD2 is linked to Alzheimer disease.